CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry CytoSorbents summarizes real-world data from STAR Registry analysis being presented next week at European Association of Cardio-Thoracic Surgery Congress

New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time PRINCETON, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

China Apixaban Market Report 2021: Analysis of Major Manufacturers 2016-2020, Prices 2020-2021 & Prospects 2021-2025 Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Apixaban Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The sales revenue of Apixaban...

Corbus Pharmaceuticals Provides Management Team Updates Mark Tepper, Ph.D., transitions to role of external Senior Scientific Advisor Robert Discordia, Ph.D., role expanded to lead Chemistry, Manufacturing and Controls operationsSergei Atamas, M.D.,...